Vsee Health Inc

Análisis de la acción Vsee Health Inc (VSEE)

$0.050

-0.020 (-40.24%)Al cierre

Loading chart…
High
0.065
Open
0.060
VWAP
0.05
Vol
43.61M
Mkt Cap
Low
0.049
Amount
2.38M
EV/EBITDA, TTM
-0.28

VSee Health, Inc. is a telehealth technology and services company delivering virtual care solutions through its application programming interface (API)-driven platform. The platform integrates secure video streaming with medical device data, electronic medical records, and other sensitive health information, offering customizable and white-labeled solutions for healthcare providers, employers, and hospital systems. The Company operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions.

vsee.com

AI analysis of Vsee Health Inc (VSEE)

hold

Vsee Health Inc (VSEE) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock exhibits bearish technical indicators, lacks positive trading signals, and has no significant catalysts or financial data to support a strong investment case. Given the investor's impatience and preference for long-term stability, this stock does not align with their goals.

Métricas de valoración

The current forward P/E ratio for Vsee Health Inc (VSEE) is 0.00, compared to its 5-year average forward P/E of -0.80.

Forward P/E

Fair
5Y Average P/E
-0.80
Current P/E
0.00
Sobrevalorada
0.52
Infravalorada
-2.12

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-1.88
Current EV/EBITDA
-0.28
Sobrevalorada
0.97
Infravalorada
-4.72

Forward P/S

Fair
5Y Average P/S
0.36
Current P/S
0.17
Sobrevalorada
0.85
Infravalorada
-0.12

Cronología de eventos

2026-07-30 (ET)

09:00:00

VSee Health Proposes Acquisition of Healthcare Tech Assets with Over $35M Annual Revenue

2026-07-29 (ET)

09:00:00

VSee Health Signs LOI for Acquisition of Healthcare Assets

2026-07-28 (ET)

09:00:00

VSee Health Initiates Strategic Review to Accelerate Growth

2026-07-22 (ET)

09:00:00

VSee Health Proposes 80-for-1 Reverse Split to Protect Shareholder Value

2026-07-14 (ET)

09:30:00

VSee Health Plans to Expand Hospital Network to 58 with AI

Noticias

VSEE FAQ — answered by Alphio AI

VSee Health, Inc. is a telehealth technology and services company delivering virtual care solutions through its application programming interface (API)-driven platform. The platform integrates secure video streaming with medical device data, electronic medical records, and other sensitive health information, offering customizable and white-labeled solutions for healthcare providers, employers, and hospital systems. The Company operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. It operates in the Technology sector.

Vsee Health Inc (VSEE) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock exhibits bearish technical indicators, lacks positive trading signals, and has no significant catalysts or financial data to support a strong investment case. Given the investor's impatience and preference for long-term stability, this stock does not align with their goals.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis